Great news. Positive trend which was begun earlier today has continued after market. Some must have had information from the meeting. Now up 6.2%.
Love the highlighted points. Quote: _________________________________________________________________
Additional highlights from Dr. Goldfarb''s presentation on Zerenex are as follows:
* Statistically significant dose response increase in serum bicarbonate suggests potential to address metabolic acidosis * Statistically significant dose response reduction in calcium x phosphorus product * Modest upward trends in Ferritin and TSAT in 6 grams/day and 8 grams/day dose groups further supports theory that Zerenex could reduce the need for intravenous iron and erythropoiesis-stimulating agent (ESA) use * Zerenex appeared to be safe and well-tolerated in the study * GI adverse events were mostly mild and transient in nature * No SAEs were deemed to be drug-related by the Data Safety Monitoring Committee ____________________________________________________________________ http://www.prnewswire.com/news-releases/keryx-biopharmaceuticals-announces-positive-final-data-from-zerenex-short-term-phase-3-study-120887829.html